Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results – AlphaStreet

News . Data . Research
Categories AlphaGraphs, Health Care
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today.
Total revenue decreased 7% year-over-year to $2.58 billion.
Net income attributable to Biogen Inc. was $1 billion, or $7.24 per share, compared to $448.5 million, or $2.99 per share, last year. Adjusted EPS was $5.25.
Biogen raised its revenue and adjusted EPS guidance for the full year of 2022 based on better-than-expected topline performance and continued cost management. For FY2022, revenue is now expected to be $9.9-10.1 billion and adjusted EPS is now expected to be $15.25-16.75 compared to the previous ranges of $9.7-10 billion for revenue and $14.25-16.00 for adjusted EPS.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis, revenues grew 14.3%. GAAP net earnings rose nearly
Very few businesses enjoy such a strong brand power as The Coca-Cola Company (NYSE: KO) does, which continues to dominate the soft drink market despite stiff competition. The company has
Hasbro, Inc. (NASDAQ: HAS) reported second quarter 2022 earnings results today. Net revenues inched up by 1% to $1.33 billion compared to the same period a year ago. On a GAAP
© 2020 AlphaStreet Inc. All Rights Reserved
[email protected]
44053 Fremont Blvd,
Fremont, CA 94538